Qualitative DNA differences between two structurally different lesions: High-grade dysplasia and carcinoma in situ in colorectal adenomas

Anticancer Research

Volumn 27, Issue 4 C, 2007, Pages 2881-2885

  Rubio, C A ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Carcinoma in situ; DNA; Dysplasia; RNA

Indexed keywords

DNA; EOSIN; HEMATOXYLIN; MESSENGER RNA;

ARTICLE; CANCER GRADING; CANCER SIZE; CARCINOMA IN SITU; CHROMATIN; CHROMOSOME MUTATION; CLINICAL ARTICLE; COLORECTAL ADENOMA; DNA DETERMINATION; DYSPLASIA; HUMAN; HUMAN TISSUE; LAMINA PROPRIA; PRIORITY JOURNAL; QUALITATIVE ANALYSIS; SPINDLE CELL;

ADENOMA; CARCINOMA IN SITU; COLORECTAL NEOPLASMS; DNA, NEOPLASM; HUMANS; ROSANILINE DYES; STAINING AND LABELING;

EID: 34547804897     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Morson BC, Whiteway JE, Jones EA, Macrae FA and Williams CB: Histopathology and prognosis of malignant colorectal polyps treated by endoscopic polypectomy. Gut 25: 437-444, 1984.
2. Loeve F, Boer R, Zauber AG, Van Ballegooijen M, Van Oortmarssen GJ, Winawer SJ and Habbema JD: National Polyp Study data: evidence for regression of adenomas. Int J Cancer 111: 633-639, 2004.
3. Ackermann S, Gehrsitz C, Mehlhorn G and Beckmann MW: Management and course of histologically verified cervical carcinoma in situ during pregnancy. Acta Obstet Gynecol Scand 85: 1134-1137, 2006.
4. Gonzalez RJ, Buzdar AU, Fraser Symmans W, Yen TW, Broglio KR, Lucci A, Esteva FJ, Yin G and Kuerer HM: Novel clinical trial designs for treatment of ductal carcinoma in situ of the breast with trastuzumab (herceptin). Breast J 13: 72-75, 2007.
5. Ondo AL, Mings SM, Pestak RM and Shanler SD: Topical combination therapy for cutaneous squamous cell carcinoma in situ with 5-fluorouracil cream and imiquimod cream in patients who have failed topical monotherapy. J Am Acad Dermatol 55: 1092-1094, 2006.
6. Raju RR, Goldblum JR and Hart WR: Pagetoid squamous cell carcinoma in situ (pagetoid Bowen's disease) of the external genitalia. Int J Gynecol Pathol 22: 127-135, 2003.
7. Wilkin TJ, Palmer S, Brudney KF, Chiasson MA and Wright TC: Anal intraepithelial neoplasia in heterosexual and homosexual HIV-positive men with access to antiretroviral therapy. J Infect Dis 190: 1685-1691, 2004.
8. Abe K, Suda K, Arakawa A, Yamasaki S, Sonoue H, Mitani K and Nobukawa B: Different patterns of p16INK4A and p53 protein expressions in intraductal papillary-mucinous neoplasms and pancreatic intraepithelial neoplasia. Pancreas 34: 85-91, 2007.
9. Yin H, He Q, Li T and Leong AS: Cytokeratin 20 and Ki-67 to distinguish carcinoma in situ from flat non-neoplastic urothelium. Appl Immunohistochem Mol Morphol 14: 260-265, 2006.
10. Snijders PJ, Breuer RH, Sutedja TG, Egging M, Voorhorst FJ, Steenbergen RD, van der Linden HC, Risse EK, Berkhof J, de Vries EG, van der Zee AG, Postmus PE, Meijer CJ and Smit EF: Elevated hTERT mRNA levels: A potential determinant of bronchial squamous cell carcinoma (in situ). Int J Cancer 109: 412-417, 2004.
11. Schlemper R J, Riddell, Kato Y, Borchard F, Cooper HS, Rubio CA, Rugge M, Shimuzu M, Watanabe H and Yamabe H: International concensus on the classification of gastrointestinal epithelial neoplasia. The Vienna classification. Gut 47: 251-255, 2000.
12. Rubio CA, Nesi G, Messerini L, Mandai K, Itabashi M and Takubo K: The Vienna classification applied to colorectal adenomas. J Hepatology and Gastroenterology 21: 1697-1703, 2006.
13. Rubio CA, Alm T, Aly A and Poppen B: Intraepithelial bodies in colorectal adenomas: Leuchtenberger bodies revisited. Dis Colon Rectum 34: 47-50, 1991.
14. Rubio CA and Porwit-McDonald A: A method to quantitate the relative nuclear area of colorectal polyps by image analysis. Anal Quant Cytol Histol 13: 155-158, 1991.
15. Morson BC, Sobin LH, Grundmann E, Johansen A, Nagayo T and Serck-Hanssen A: Precancerous conditions and epithelial dysplasia in the stomach. J Clin Pathol 33: 711-721, 1980.
16. Nagayo T: Dysplasia of the gastric mucosa and its elation to the pecanceous state Gann 72: 813-823, 1981.
17. Fenoglio-Preiser C, Lantz P, Lindstrom M, Davies M and Rilke F: Gastrointestinal Pathology. An Atlas and Text. Raven Press, New York, Second Edition, pp. 909-1068, 1989.
18. Miyaki M, Iijima T, Yamaguchi T, Hishima T, Tamura K, Utsunomiya J and Mori T: Germline mutations of the MYH gene in Japanese patients with multiple colorectal adenomas. Mutat Res 578: 430-433, 2005.
19. Fujii S, Fujimori T, Kawamata H, Takeda J, Kitajima K, Omotehara F, Kaihara T, Kusaka T, Ichikawa K, Ohkura Y, Ono Y, Imura J, Yamaoka S, Sakamoto C, Ueda Y and Chiba T: Development of colonic neoplasia in p53 deficient mice with experimental colitis induced by dextran sulphate sodium. Gut 53: 710-716, 2004.
20. Sugai T, Habano W, Uesugi N, Jiao YF, Nakamura S, Sato K, Chiba T and Ishii M: Molecular validation of the modified Vienna classification of colorectal tumors. J Mol Diagn 4: 191-200, 2002.
21. Galamb O, Sipos F, Dinya E, Spisak S, Tulassay Z and Molnar B: mRNA expression, functional profiling and multivariate classification of colon biopsy specimen by cDNA overall glass microarray. World J Gastroenterol 12: 6998-7006, 2006.
22. Kim JH, Kang MJ, Park CU, Kwak HJ, Hwang Y and Koh GY: Amplified CDK2 and cdc2 activities in primary colorectal carcinoma. Cancer 85: 546-553, 1999.
23. Bosari S, Viale G, Bossi P, Maggioni M, Coggi G, Murray JJ and Lee AK: Cytoplasmic accumulation of p53 protein: an independent prognostic indicator in colorectal adenocarcinomas. J Natl Cancer Inst 86: 681-687, 1994.
24. Lu M, Nakamura RM, Dent ED, Zhang JY, Nielsen FC, Christiansen J, Chan EK and Tan EM: Aberrant expression of fetal RNA-binding protein p62 in liver cancer and liver cirrhosis. Am J Pathol 159: 945-953, 2001.
25. Zhang JY, Chan EK, Peng XX and Tan EM: A novel cytoplasmic protein with RNA-binding motifs is an autoantigen in human hepatocellular carcinoma. J Exp Med 189: 1101-1110, 1999.
26. Neufeld KL and White R: Nuclear and cytoplasmic localizations of the adenomatous polyposis coli protein. Proc Natl Acad Sci USA 94: 3034-3039, 1997.
27. Smith DP, Rayter SI, Niederlander C, Spicer J, Jones CM and Ashworth A: LIP1, a cytoplasmic protein functionally linked to the Peutz-Jeghers syndrome kinase LKB1. Hum Mol Genet 10: 2869-2877, 2001.
28. Chedin M, Filhol O, Duminy C, Bolla M, Benistant C, Roche S, Chambaz EM and Cochet C: Characterization of two different cytoplasmic protein tyrosine kinases from human breast cancer. Carcinogenesis 18: 1463-472, 1997.